158 related articles for article (PubMed ID: 35896237)
21. Primary central nervous system posttransplantation lymphoproliferative disorder after heart and lung transplantation.
Gifford G; Fay K; Jabbour A; Ma DD
Intern Med J; 2015 May; 45(5):583-6. PubMed ID: 25955465
[TBL] [Abstract][Full Text] [Related]
22. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Allen UD; Preiksaitis JK;
Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
[TBL] [Abstract][Full Text] [Related]
23. Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature.
Banks CA; Meier JD; Stallworth CR; White DR
Ann Otol Rhinol Laryngol; 2012 May; 121(5):291-5. PubMed ID: 22724273
[TBL] [Abstract][Full Text] [Related]
24. Primary CNS post-transplant lymphoproliferative disorder following haploidentical HSCT using post-transplant high-dose cyclophosphamide.
Toyosaki M; Onizuka M; Amaki J; Shiraiwa S; Aoyama Y; Machida S; Kawai H; Murayama H; Ogiya D; Matsui K; Kawakami S; Harada K; Kondo Y; Hirabayashi K; Nakamura N; Ogawa Y; Kawada H; Ando K
Blood Cell Ther; 2019 Feb; 2(1):1-4. PubMed ID: 37969696
[TBL] [Abstract][Full Text] [Related]
25. Risk factors evaluation of post-transplant lymphoproliferative disorders after allogeneic haematopoietic stem cell transplantation with comparison between paediatric and adult.
Chen DB; Liu XY; Kong FZ; Jiang Q; Shen DH
J Clin Pathol; 2021 Nov; 74(11):697-703. PubMed ID: 34011618
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-immunotherapy.
Inoue H; Rai S; Tanaka H; Espinoza JL; Komori-Inoue M; Kakutani H; Minamoto S; Kumode T; Nakayama S; Taniguchi Y; Morita Y; Okuda T; Tatsumi Y; Ashida T; Matsumura I
Viruses; 2020 Apr; 12(4):. PubMed ID: 32276450
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantation.
Kalra A; Roessner C; Jupp J; Williamson T; Tellier R; Chaudhry A; Khan F; Taparia M; Jimenez-Zepeda VH; Stewart DA; Daly A; Storek J
Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29114932
[TBL] [Abstract][Full Text] [Related]
28. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
[TBL] [Abstract][Full Text] [Related]
29. Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.
Ganne V; Siddiqi N; Kamaplath B; Chang CC; Cohen EP; Bresnahan BA; Hariharan S
Clin Transplant; 2003 Oct; 17(5):417-22. PubMed ID: 14703923
[TBL] [Abstract][Full Text] [Related]
30. Primary central nervous system post-transplantation lymphoproliferative disorder: A case report and systematic review of imaging findings.
Hoyt D; Hughes J; Liu J; Ayyad H
Radiol Case Rep; 2024 Jun; 19(6):2168-2182. PubMed ID: 38515768
[TBL] [Abstract][Full Text] [Related]
31. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation.
Chen DB; Song QJ; Chen YX; Chen YH; Shen DH
Int J Hematol; 2013 Jan; 97(1):117-24. PubMed ID: 23255160
[TBL] [Abstract][Full Text] [Related]
33. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
34. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
Romero S; Montoro J; Guinot M; Almenar L; Andreu R; Balaguer A; Beneyto I; Espí J; Gómez-Codina J; Iacoboni G; Jarque I; López-Andújar R; Mayordomo-Aranda E; Montalar J; Pastor A; Pastor M; Piñana JL; Rojas-Ferrer N; Sánchez-Lázaro I; Sandoval J; Sanz G; Sanz MÁ; Solé A; Sanz J
Leuk Lymphoma; 2019 Jan; 60(1):142-150. PubMed ID: 29966464
[TBL] [Abstract][Full Text] [Related]
35. Primary Cutaneous Polymorphic EBV-Associated Posttransplant Lymphoproliferative Disorder After a Renal Transplant and Review of the Literature.
Ferguson NN; Thomas CP; Hohl RJ; Syrbu SI; Stone MS; Wanat KA
Am J Dermatopathol; 2015 Oct; 37(10):790-4. PubMed ID: 25747810
[TBL] [Abstract][Full Text] [Related]
36. A disease warranting attention from neurosurgeons: primary central nervous system post-transplant lymphoproliferative disorder.
Jin L; Lu D; Yan F; Han J; Wei P; Zhou Y; Wang Y; Shan Y; Zhao G
Front Neurol; 2024; 15():1392691. PubMed ID: 38813246
[TBL] [Abstract][Full Text] [Related]
37. Orbital Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a 13-year-old girl with cord blood transplantation.
Shigemura T; Maruyama Y; Shigeto S; Nakazawa Y; Kanno H
Transpl Infect Dis; 2021 Jun; 23(3):e13536. PubMed ID: 33264446
[TBL] [Abstract][Full Text] [Related]
38. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
Trappe R; Oertel S; Leblond V; Mollee P; Sender M; Reinke P; Neuhaus R; Lehmkuhl H; Horst HA; Salles G; Morschhauser F; Jaccard A; Lamy T; Leithäuser M; Zimmermann H; Anagnostopoulos I; Raphael M; Riess H; Choquet S; ;
Lancet Oncol; 2012 Feb; 13(2):196-206. PubMed ID: 22173060
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder following lung transplantation is more commonly of host origin.
Peterson MR; Emery SC; Yung GL; Masliah E; Yi ES
Arch Pathol Lab Med; 2006 Feb; 130(2):176-80. PubMed ID: 16454557
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of central nervous system PTLD with rituximab and cranial radiotherapy.
Said-Conti V; Amrolia PJ; Gaze MN; Stoneham S; Sebire N; Shroff R; Marks SD
Pediatr Nephrol; 2013 Oct; 28(10):2053-6. PubMed ID: 23743853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
